Technology News and Research

RSS

Touch Bionics wins Queen's Awards for Enterprise in Innovation category for 2010

Touch Bionics, developer of advanced upper-limb bionic technologies, today announced it is a winner of the prestigious Queen's Awards for Enterprise with an award in the Innovation category for 2010. The Queen's Awards for Enterprise are the UK's most prestigious awards for business performance.

21 Apr 2010

Clarient Insight Dx Pulmotax assay helps predict response to chemotherapy in lung cancer patients

Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that data from a new study suggest that the Clarient Insight® Dx Pulmotax™ assay may effectively predict which lung cancer patients will respond favorably to chemotherapy. The study, titled "TLE3 expression is predictive of response to chemotherapy in NSCLC," included 368 samples from carcinoma patients.

21 Apr 2010

New self-referencing glutamate biosensor to measure glutamate flux of neural cells in living organism

A new biosensor developed at Purdue University can measure whether neurons are performing correctly when communicating with each other, giving researchers a tool to test the effectiveness of new epilepsy or seizure treatments.

21 Apr 2010

MicroStockProfit.com: CUR reports net loss of $5,096,983 for third-quarter of 2009

MicroStockProfit.com announces an investment report featuring Neuralstem Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

21 Apr 2010

Posit Science challenges BBC study on cognitive training programs

Posit Science, the leader in clinically proven brain fitness programs, contests the interpretation and methodology used in a British Broadcasting Corporation-sponsored study published in the journal Nature.

21 Apr 2010

Ajinomoto AminoScience introduces new resource for peptides

Ajinomoto AminoScience, LLC announced today the launch of AjiPhase™, an evolution of liquid phase peptide synthesis containing the benefits of solid and liquid phase methodologies. This new service is designed as an innovative tool that will enable pharmaceutical companies to expand their development pipeline and provide a uniform production process through the entire development lifecycle.

21 Apr 2010

Concateno bestowed Queen's Award for Enterprise

Concateno (>Europe's leading drug and alcohol test provider, has been awarded the prestigious Queen's Award for Enterprise (http://www.queensawards.org.uk/business/business.html ) in recognition of its outstanding innovation and commercial performance.

21 Apr 2010

LDR completes IDE study on Mobi-C cervical artificial disc

LDR, a privately held company with innovative spinal implants for non-fusion and fusion applications, announced completion of the 24-month follow-up phase of its two-level IDE study on the Mobi-C cervical artificial disc. Having previously finalized the 24-month follow-up phase of the one-level study earlier this year, LDR is now the first company to fully enroll and reach two-year follow-up on a concurrent one-level and two-level cervical artificial disc replacement study.

21 Apr 2010

Tea for Teal event raises $15,000 for TGen ovarian cancer research

The Anne Rita Monahan Foundation recently presented $15,000 for ovarian cancer research to the Translational Genomics Research Institute (TGen).

21 Apr 2010

"Destination therapy" for end-stage heart failure patients

Federal approval for an alternative therapy to heart transplantation led to a new lease on life for a UT Southwestern Medical Center patient who suffered from heart failure for nearly a decade.

21 Apr 2010

Simcyp wins Queen's Award for Enterprise for innovative research and development

Simcyp Limited, experts in simulating how the body deals with new drugs in development, today announces that it has won a Queen's Award for Enterprise. The award has been made in the Innovation category and reflects Simcyp's continuous development of modelling and simulation software for evaluating drugs in the safety of a computer.

21 Apr 2010

DSM Biomedical, CID partner on use of ComfortCoat Hydrophilic coating technology

DSM Biomedical, a global leader in biomedical materials science, today announced the extension of its partnership with CID based on the use of DSM ComfortCoat® Hydrophilic coating technology on the Optima Jet Stent Delivery System and the Fluydo PTCA Balloon Catheter, both with CE marked and launched on the European market last month.

21 Apr 2010

Gene test predicts statins' effectiveness in reducing risk of colorectal cancer

A genetic test can help determine in which patients cholesterol-lowering statin drugs might have the most benefit in also reducing the risk of colorectal cancer, a new study from researchers at the University of Michigan Comprehensive Cancer Center finds.

21 Apr 2010

New sensor wristband monitors various body functions

A small blood lab that fits into the pocket of a jacket can quickly analyze the risk of blood clots in legs prior to a long distance flight; a sensor wristband for measuring electric smog can warn pacemaker patients of life-threatening exposure: "Smart plastics" can turn such tools into reality.

21 Apr 2010

State Round Up: Colorado's medical marijuana dispensaries; Insurance discounts for wellness; Florida's pain clinic oversight legislation

Hundreds of new medical marijuana dispensaries have cropped up in Denver, Boulder and other Colorado cities, causing the state to stop accepting walk-up applications from people seeking cards that allow them to buy the plant, CNBC/USA Today reports. Would-be medical-marijuana consumers will now have to mail in their applications. "The changes are necessary due to the explosive growth in the number of medical marijuana applications," said a state health official.

21 Apr 2010

Roche's progress of RG7348 into Phase I clinical trial triggers $6.5M milestone payment to Ligand

Ligand Pharmaceuticals Incorporated today announced that it earned a $6.5 million payment from Roche as a result of Roche progressing RG7348 into a Phase I clinical trial for the treatment of hepatitis C viral (HCV) infection. The milestone payment arises from a 2008 collaboration and license agreement between Roche and Metabasis Therapeutics, Inc.

21 Apr 2010

miRNAs may generate new insights on cancer and possible future treatments

Scientists are methodically unlocking the biological processes that lead to cancer, and recent discoveries with microRNAs (miRNAs) are revolutionizing their understanding and leading to clinical trials of potentially effective treatments.

21 Apr 2010

Listening to personal music players can induce hearing loss

Young people who listen to personal music players for several hours a day at high volume could be putting their hearing at risk, warns an expert in an editorial published on bmj.com today.

21 Apr 2010

InfoLogix launches HealthTrax mobility solution for University Health System

InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, announced today it has successfully launched a customized HealthTrax mobility solution for University Health System's 604-bed acute care hospital and 20 ambulatory clinics in San Antonio, Texas.

21 Apr 2010

Ghent University signs agreement to use Roche's LightCycler 1536 Instrument for cancer research

Roche and Ghent University (Belgium) have signed an agreement for the use of Roche's LightCycler® 1536 Instrument in various cancer research projects in Ghent. Studies include multigene expression signature profiling on cancer research samples and, digital PCR for sensitive detection of mutant cancer cells in a background of normal cells.

21 Apr 2010

Technology News and Research

Touch Bionics wins Queen's Awards for Enterprise in Innovation category for 2010

Clarient Insight Dx Pulmotax assay helps predict response to chemotherapy in lung cancer patients

New self-referencing glutamate biosensor to measure glutamate flux of neural cells in living organism

MicroStockProfit.com: CUR reports net loss of $5,096,983 for third-quarter of 2009

Posit Science challenges BBC study on cognitive training programs

Ajinomoto AminoScience introduces new resource for peptides

Concateno bestowed Queen's Award for Enterprise

LDR completes IDE study on Mobi-C cervical artificial disc

Tea for Teal event raises $15,000 for TGen ovarian cancer research

"Destination therapy" for end-stage heart failure patients

Simcyp wins Queen's Award for Enterprise for innovative research and development

DSM Biomedical, CID partner on use of ComfortCoat Hydrophilic coating technology

Gene test predicts statins' effectiveness in reducing risk of colorectal cancer

New sensor wristband monitors various body functions

State Round Up: Colorado's medical marijuana dispensaries; Insurance discounts for wellness; Florida's pain clinic oversight legislation

Roche's progress of RG7348 into Phase I clinical trial triggers $6.5M milestone payment to Ligand

miRNAs may generate new insights on cancer and possible future treatments

Listening to personal music players can induce hearing loss

InfoLogix launches HealthTrax mobility solution for University Health System

Ghent University signs agreement to use Roche's LightCycler 1536 Instrument for cancer research

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News